EP2331084A4 - PHARMACEUTICAL COMPOSITIONS COMPRISING AMORPHOUS ESOMEPRAZOLE, PHARMACEUTICAL FORMS AND METHOD THEREOF - Google Patents

PHARMACEUTICAL COMPOSITIONS COMPRISING AMORPHOUS ESOMEPRAZOLE, PHARMACEUTICAL FORMS AND METHOD THEREOF

Info

Publication number
EP2331084A4
EP2331084A4 EP09818889.9A EP09818889A EP2331084A4 EP 2331084 A4 EP2331084 A4 EP 2331084A4 EP 09818889 A EP09818889 A EP 09818889A EP 2331084 A4 EP2331084 A4 EP 2331084A4
Authority
EP
European Patent Office
Prior art keywords
pharmaceutical
pharmaceutical compositions
amorphous esomeprazole
forms
pharmaceutical forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09818889.9A
Other languages
German (de)
French (fr)
Other versions
EP2331084A1 (en
Inventor
Gopal Rajan
Pratik Kumar
Gour Mukherji
Pulak Kumar Metia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jubilant Pharmova Ltd
Original Assignee
Jubilant Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jubilant Life Sciences Ltd filed Critical Jubilant Life Sciences Ltd
Publication of EP2331084A1 publication Critical patent/EP2331084A1/en
Publication of EP2331084A4 publication Critical patent/EP2331084A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP09818889.9A 2008-10-06 2009-10-06 PHARMACEUTICAL COMPOSITIONS COMPRISING AMORPHOUS ESOMEPRAZOLE, PHARMACEUTICAL FORMS AND METHOD THEREOF Withdrawn EP2331084A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2315DE2008 2008-10-06
PCT/IN2009/000553 WO2010041276A1 (en) 2008-10-06 2009-10-06 Pharmaceutical compositions comprising amorphous esomeprazole, dosage forms and process thereof

Publications (2)

Publication Number Publication Date
EP2331084A1 EP2331084A1 (en) 2011-06-15
EP2331084A4 true EP2331084A4 (en) 2014-01-22

Family

ID=42100256

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09818889.9A Withdrawn EP2331084A4 (en) 2008-10-06 2009-10-06 PHARMACEUTICAL COMPOSITIONS COMPRISING AMORPHOUS ESOMEPRAZOLE, PHARMACEUTICAL FORMS AND METHOD THEREOF

Country Status (2)

Country Link
EP (1) EP2331084A4 (en)
WO (1) WO2010041276A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011140446A2 (en) * 2010-05-06 2011-11-10 Dr. Reddy's Laboratories Ltd. Pharmaceutical formulations
WO2011154009A1 (en) * 2010-06-10 2011-12-15 Lifecycle Pharma A/S Composition comprising an active principle in an amorphous form and a porous adsorbent material
IT1401284B1 (en) * 2010-08-06 2013-07-18 Valpharma S P A NEW PHARMACEUTICAL FORMULATIONS SUITABLE FOR ORAL ADMINISTRATION OF DIHYDRATE ESOMEPRAZOLE MAGNESIUM, IN THE FORM OF MUPS TABLETS (MULTI UNIT PELLETS SYSTEM).
EP2604256B1 (en) * 2011-12-14 2016-04-13 Hexal AG Multi layer coatings
CN103462924A (en) * 2012-06-06 2013-12-25 南京亿华药业有限公司 Prescription and preparation method of esomeprazole sustained release tablet
CN103520226B (en) * 2013-10-11 2015-09-02 惠州市九惠制药股份有限公司 A kind of pH dependent form conlon targeting hard capsule
EP3292862A1 (en) * 2016-09-07 2018-03-14 Sandoz Ag Omeprazole formulations

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1801110A1 (en) * 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050214372A1 (en) * 2004-03-03 2005-09-29 Simona Di Capua Stable pharmaceutical composition comprising an acid labile drug
AR057181A1 (en) * 2005-11-30 2007-11-21 Astra Ab NEW COMBINATION DOSAGE FORM
EP1813275A1 (en) * 2005-12-20 2007-08-01 Teva Pharmaceutical Industries Ltd Lansoprazole orally disintegrating tablets
SI2007362T1 (en) * 2006-04-04 2018-12-31 Kg Acquisition Llc Oral dosage forms including an antiplatelet agent and an acid inhibitor
WO2008018825A1 (en) * 2006-08-10 2008-02-14 Astrazeneca Ab Oral polyvinyl alcohol capsules comprising proton pump inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1801110A1 (en) * 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2010041276A1 *

Also Published As

Publication number Publication date
WO2010041276A1 (en) 2010-04-15
EP2331084A1 (en) 2011-06-15

Similar Documents

Publication Publication Date Title
BRPI0917358A2 (en) controlled release pharmaceutical formulation and method.
BRPI0918652A2 (en) Pharmaceutical compositions and related release methods.
BRPI0914902A2 (en) pharmaceutical composition and method for treating parkinson's disease
BRPI0908596A2 (en) prolonged release formulation and pharmaceutical composition
EP2240022A4 (en) PHARMACEUTICAL COMPOSITIONS
BRPI0822825A2 (en) Oral Care Implement, and Method for Forming an Oral Care Implement
DK2346495T4 (en) PHARMACEUTICAL FORMULATION 514
EP2296744A4 (en) ANNULOPLASTIC DEVICES AND METHOD FOR THEIR ADMINISTRATION
CY2016053I2 (en) TREATMENT METHODS USING AMMONIA-TRACKING PHARMACEUTICAL SUBSTANCES
BRPI0920515A2 (en) Methods for producing polymer nanoparticles and active ingredient formulations
BRPI0909780A2 (en) Compositions and methods for drug release
EP2373681A4 (en) PHARMACEUTICAL COMPOSITIONS
BRPI0923836A2 (en) Opioid-containing oral pharmaceutical compositions and methods
BRPI0906453A2 (en) Oral Care Composition and Method for Improving Oral Health
BRPI0905361A2 (en) Imaging apparatus and method, and, program
EP2124556A4 (en) PHARMACEUTICAL COMPOSITIONS
BRPI0921654A2 (en) pharmaceutical formulation
EP2154966A4 (en) BENZIMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS THEREOF
EP2320740A4 (en) PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR PRODUCING LOW IMPURITY CONCENTRATIONS THEREOF
BRPI0907646A2 (en) Effervescent soluble solid composition, and method for cleaning a dental device
NL1037040A1 (en) Coating compositions and method for their preparation.
EP2331084A4 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING AMORPHOUS ESOMEPRAZOLE, PHARMACEUTICAL FORMS AND METHOD THEREOF
ATE502024T1 (en) DIOSMETIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
BRPI0912428A2 (en) solid delayed release pharmaceutical formulation
EP2257316A4 (en) CONTRAST AGENTS, METHODS FOR PREPARING CONTRAST AGENTS, AND IMAGING METHODS

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110328

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20140103

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/4439 20060101ALI20131218BHEP

Ipc: A61K 9/54 20060101AFI20131218BHEP

Ipc: A61K 33/06 20060101ALI20131218BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20150109

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150520